Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin’s Lymphoma

Until recently, patients with relapsed Hodgkin’s lymphoma after brentuximab vedotin (Bv) treatments had poor treatment outcomes. Checkpoint inhibitors such as nivolumab and pembrolizumab that bind to and inhibit programmed cell death protein-1 (PD-1), have demonstrated an overall response rate of 70...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Res
Main Authors: Qin, Qian, Nan, Xinyu, Miller, Tara, Fisher, Ronald, Teh, Bin, Pandita, Shruti, Farach, Andrew M., Pingali, Sai Ravi, Pandita, Raj K., Butler, E. Brian, Pandita, Tej K., Iyer, Swaminathan P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135239/
https://ncbi.nlm.nih.gov/pubmed/29949442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR15048.1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados